SDI Ltd
ASX:SDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Raisio Oyj
OMXH:RAIVV
|
FI |
|
T
|
Tus Pharmaceutical Group Co Ltd
SZSE:000590
|
CN |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (8.2), the stock would be worth AU$0.96 (22% downside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10.4 | AU$1.23 |
0%
|
| 3-Year Average | 8.2 | AU$0.96 |
-22%
|
| 5-Year Average | 8.6 | AU$1.01 |
-18%
|
| Industry Average | 25.5 | AU$3 |
+144%
|
| Country Average | 16.5 | AU$1.95 |
+59%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
AU$161.1m
|
/ |
Jan 2026
AU$15.1m
|
= |
|
|
AU$161.1m
|
/ |
Jun 2026
AU$24.2m
|
= |
|
|
AU$161.1m
|
/ |
Jun 2027
AU$27.3m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
SDI Ltd
ASX:SDI
|
147.4m AUD | 10.4 | 12.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62B USD | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.7T JPY | 28.1 | 38.7 | |
| CH |
|
Alcon AG
SIX:ALC
|
30.1B CHF | 14.5 | 37.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.5B DKK | 12.7 | 24 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
14B USD | 14.9 | 34.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.5B GBP | 11.9 | 34.3 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.7B USD | 16.9 | -15.7 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8T KRW | -81.4 | -36.4 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
868.9B JPY | 23.2 | 49.1 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 14.7 | 22.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 10 |
| Median | 16.5 |
| 70th Percentile | 24.5 |
| Max | 6 797.5 |
Other Multiples
SDI Ltd
Glance View
SDI Ltd. engages in the research, development, manufacturing, and marketing of dental restorative products, tooth whitening systems, and small dental equipment for sale to dental distributors, dental dealers and dentists worldwide. The company is headquartered in Bayswater, Victoria. The company manufactures dental restorative products, tooth whitening systems and small dental equipment for sale to dental distributors, dental dealers and dentists around the world. The firm's segments include Australia, Europe, United States and Brazil. Australia segment includes SDI Limited and SDI Dentech Innovations Pty Limited. Europe segment includes SDI Germany GmbH (Germany) and SDI Dental Innovations Limited (United Kingdom). United States segment includes SDI (North America), Inc. Brazil segment includes SDI Brasil Industria e Comercio Ltda. The firm's product categories include alloys, etchants, adhesives, glass ionomers, sealants, composites, cements, tooth whitening, equipment, accessories and SDF Riva Star. Its products are distributed through distributors and retailers in over 100 countries.
